Zugriffe | |
---|---|
GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma | 111 |
Dezember 2023 | Januar 2024 | Februar 2024 | März 2024 | April 2024 | Mai 2024 | Juni 2024 | |
---|---|---|---|---|---|---|---|
GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma | 3 | 4 | 8 | 2 | 3 | 4 | 4 |
Zugriffe | |
---|---|
2021_Zirngibl_etal.pdf | 147 |